This ability of HPAF-II cells to inhibit T-cell proliferation and IFNγ/GMCSF release was fully reversed upon pretreatment of the cancer cells with RXC004 (Fig. 7A–C; Supplementary Fig. S7A). Here, CSF2 is linked to cancer.